Felipe Alberto-Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Felipe Alberto-Lei has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Rodrigo Cayô
Laboratório Alerta, Division of Infectious Diseases, Department of Internal Medicine, Universidade Federal de São Paulo (UNIFESP)
6 shared publications- Carolina Silva Nodari
Institute Pasteur
4 shared publications - Ana Christina Gales
Universidade Federal de São Paulo
3 shared publications Ana Cristina Gales
Laboratório Alerta, Division of Infectious Diseases, Department of Internal Medicine, Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina (EPM), São Paulo, Brazil
3 shared publicationsAna Paula Streling
Universidade Federal de São Paulo (UNIFESP), Laboratório ALERTA, Disciplina de Infectologia, Departamento de Medicina, Escola Paulista de Medicina (EPM) , São Paulo, SP , Brazil
3 shared publicationsFernanda Fernandes Santos
Laboratório Especial de Microbiologia Clínica (LEMC), Departamento de Medicina, Disciplina de Infectologia, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
3 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (12) , e0070725
IS Aba1 -mediated bla ADC disruption restores third-generation cephalosporin susceptibility in a clinical Acinetobacter baumannii isolate
This study describes the effects of the insertion of IS Aba1 in the intrinsic bla ADC gene of an Acinetobacter baumannii isolate showing co-resistance to carbapenems and colistin. Isolate 52971 showed low ceftazidime MIC values due to the disruption of bla ADC-195 by this insertion sequence. The introduction of an intact bla ADC in isolate 52971 increased ceftazidime MIC. The potential of insertion sequences to inactivate chromosome-encoded resistance determinants should be explored.
- 10 December 2025
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (12) , e0070725
Open AccessIS Aba1 -mediated bla ADC disruption restores third-generation cephalosporin susceptibility in a clinical Acinetobacter baumannii isolate
This study describes the effects of the insertion of IS Aba1 in the intrinsic bla ADC gene of an Acinetobacter baumannii isolate showing co-resistance to carbapenems and colistin. Isolate 52971 showed low ceftazidime MIC values due to the disruption of bla ADC-195 by this insertion sequence. The introduction of an intact bla ADC in isolate 52971 increased ceftazidime MIC. The potential of insertion sequences to inactivate chromosome-encoded resistance determinants should be explored.
- Open Access
- 2 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Comparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections
Staphylococcus epidermidis is an opportunistic commensal cutaneous biofilm-producing agent frequently causing musculoskeletal infections (MSI) with/without implants. This study was design to evaluate phenotypic and genomic relatedness between commensal skin and MSI S. epidermidis isolates and to assess patient-related and microbial markers in the outcome of patients after one-year follow-up. Demographics, clinical data and monomicrobial S. epidermidis isolates of MSI patients (n = 31) and healthy individuals (n = 15) were analyzed. Phenotypic profile was assessed by susceptibility tests by broth microdilution and biofilm formation. Phylogenetic relationships, resistome characterization, and virulome analysis were carried out by complete genome sequencing (n = 46). Overall, MSI-derived isolates were significantly more strong/moderate biofilm producers and depicted higher rates of resistance to methicillin (MRSE), ciprofloxacin, gentamicin and rifampicin. Demographics and clinical characteristics did not significantly affect MSI patients’ outcomes. In the whole-genomic sequencing (WGS) phylogeny, most MSI-derived isolates were grouped into the pathogenic-associated clonal complex CC2, and significantly higher prevalence of mecA gene and pathogenic marker IS256. Following multivariate analysis, MSI-derived isolates carrying transposable element IS256 are more likely to develop a persistent infection (odds ratio [OR], 8.00, [95% confidence interval (CI), 1.06 to 60.31], P = 0.044), while weaker biofilm producer were protectors (OR, 0.070, 95%CI, 0.005–0.979, P = 0.048), reducing the chance of recurrence by 93% (1–0.070). The logistic regression model’s performance was evaluated by Nagelkerke’s R, which resulted in 47.21%. In conclusion, S. epidermidis isolates producing MSI were phenotypically and genetically distinct from commensals, proven the association between independent genetic traits and patient’s outcome.
- 2 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessComparative genomic analysis of resistance and virulence genes in staphylococcus epidermidis and their impact on clinical outcome of musculoskeletal infections
Staphylococcus epidermidis is an opportunistic commensal cutaneous biofilm-producing agent frequently causing musculoskeletal infections (MSI) with/without implants. This study was design to evaluate phenotypic and genomic relatedness between commensal skin and MSI S. epidermidis isolates and to assess patient-related and microbial markers in the outcome of patients after one-year follow-up. Demographics, clinical data and monomicrobial S. epidermidis isolates of MSI patients (n = 31) and healthy individuals (n = 15) were analyzed. Phenotypic profile was assessed by susceptibility tests by broth microdilution and biofilm formation. Phylogenetic relationships, resistome characterization, and virulome analysis were carried out by complete genome sequencing (n = 46). Overall, MSI-derived isolates were significantly more strong/moderate biofilm producers and depicted higher rates of resistance to methicillin (MRSE), ciprofloxacin, gentamicin and rifampicin. Demographics and clinical characteristics did not significantly affect MSI patients’ outcomes. In the whole-genomic sequencing (WGS) phylogeny, most MSI-derived isolates were grouped into the pathogenic-associated clonal complex CC2, and significantly higher prevalence of mecA gene and pathogenic marker IS256. Following multivariate analysis, MSI-derived isolates carrying transposable element IS256 are more likely to develop a persistent infection (odds ratio [OR], 8.00, [95% confidence interval (CI), 1.06 to 60.31], P = 0.044), while weaker biofilm producer were protectors (OR, 0.070, 95%CI, 0.005–0.979, P = 0.048), reducing the chance of recurrence by 93% (1–0.070). The logistic regression model’s performance was evaluated by Nagelkerke’s R, which resulted in 47.21%. In conclusion, S. epidermidis isolates producing MSI were phenotypically and genetically distinct from commensals, proven the association between independent genetic traits and patient’s outcome.
- Open Access
- 16 December 2024
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 18 (12) , e70011
Impact of Variants, Epidemiological Trends, and Comorbidities on Hospitalization Rates of Unvaccinated Children in Brazil: A Retrospective Study (2020–2022)
This retrospective study aimed to investigate the impact of the emergence of new variants and the epidemiological scenario on hospitalization rates of unvaccinated children (0–12 years) in Brazil. The study included 1614 children admitted to a hospital between March 2020 and December 2022 but 101 (6.3%) of them testing positive for COVID‐19 via RT‐PCR. The frequency of COVID‐19 cases increased from 7.5% in 2020 to 9.3% in 2022 with the emergence of the Omicron variant. Children over 5 years old with comorbidities accounted for most cases (69% [70/101]). Sickle cell anemia was the most frequent comorbidity (20%), and influenza‐like illness (36% [36/101]) and decompensation of underlying disease (33% [33/101]) were the main reasons for hospitalization. Coinfection was detected in 11% of cases, with respiratory syncytial virus (RSV) being the most common viral pathogen (71%). Hospital readmission occurred in 26% of cases, with a higher frequency in children over 5 years old. The death rate was 1.9%, with comorbidities such as cystic fibrosis and congenital heart disease as risk factors. These findings emphasize the need to prioritize vaccination with monovalent Omicron XBB for high‐risk groups, including children over 5 years old with comorbidities, to mitigate the impact of new variants and reduce severe disease outcomes.
- 16 December 2024
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 18 (12) , e70011
Open AccessImpact of Variants, Epidemiological Trends, and Comorbidities on Hospitalization Rates of Unvaccinated Children in Brazil: A Retrospective Study (2020–2022)
This retrospective study aimed to investigate the impact of the emergence of new variants and the epidemiological scenario on hospitalization rates of unvaccinated children (0–12 years) in Brazil. The study included 1614 children admitted to a hospital between March 2020 and December 2022 but 101 (6.3%) of them testing positive for COVID‐19 via RT‐PCR. The frequency of COVID‐19 cases increased from 7.5% in 2020 to 9.3% in 2022 with the emergence of the Omicron variant. Children over 5 years old with comorbidities accounted for most cases (69% [70/101]). Sickle cell anemia was the most frequent comorbidity (20%), and influenza‐like illness (36% [36/101]) and decompensation of underlying disease (33% [33/101]) were the main reasons for hospitalization. Coinfection was detected in 11% of cases, with respiratory syncytial virus (RSV) being the most common viral pathogen (71%). Hospital readmission occurred in 26% of cases, with a higher frequency in children over 5 years old. The death rate was 1.9%, with comorbidities such as cystic fibrosis and congenital heart disease as risk factors. These findings emphasize the need to prioritize vaccination with monovalent Omicron XBB for high‐risk groups, including children over 5 years old with comorbidities, to mitigate the impact of new variants and reduce severe disease outcomes.
- Open Access
- 2 November 2024
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 28
OR-03 - O PAPEL DOS GENES DE RESISTÊNCIA E VIRULÊNCIA EM CEPAS DE STAPHYLOCOCCUS EPIDERMIDIS NA PATOGÊNESE E NO RESULTADO CLÍNICO DE INFECÇÕES MUSCULOESQUELÉTICAS: UMA ANÁLISE GENÔMICA COMPARATIVA
- 2 November 2024
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 28
Open AccessOR-03 - O PAPEL DOS GENES DE RESISTÊNCIA E VIRULÊNCIA EM CEPAS DE STAPHYLOCOCCUS EPIDERMIDIS NA PATOGÊNESE E NO RESULTADO CLÍNICO DE INFECÇÕES MUSCULOESQUELÉTICAS: UMA ANÁLISE GENÔMICA COMPARATIVA
- 3 September 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (4) , 3759-3767
Detection of virulent Klebsiella pneumoniae strains causing intestinal and extraintestinal infections during the 80s and 90s in Brazil
- 3 September 2024
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 55 (4) , 3759-3767
Detection of virulent Klebsiella pneumoniae strains causing intestinal and extraintestinal infections during the 80s and 90s in Brazil
- 9 December 2023
- Published by Elsevier in Public Health
- Vol. 226, 159-164
Respiratory virus detection among healthcare professionals in Brazil: work-related contact and episode recurrence during the COVID-19 pandemic
- 9 December 2023
- Published by Elsevier in Public Health
- Vol. 226, 159-164
Respiratory virus detection among healthcare professionals in Brazil: work-related contact and episode recurrence during the COVID-19 pandemic
- Open Access
- 11 April 2023
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 78 (6) , 1359-1366
Genetic and biochemical characterization of BIM-1, a novel acquired subgroup B1 MBL found in a Pseudomonas sp. strain from the Brazilian Amazon region
To characterize a novel acquired MBL, BIM-1, in a Pseudomonas #2 (subgroup P. guariconensis) strain isolated from the Aurá river located in the Brazilian Amazon hydrographic basin. WGS using an Illumina® MiSeq System was used to characterize the genome of Pseudomonas sp. IEC33019 strain. Southern blotting/hybridization assays were performed to confirm the location of the MBL-encoding gene, blaBIM-1 (Belém Imipenemase). Antimicrobial susceptibility testing, cloning, and biochemical and phenotypic characterization were performed to determine BIM-1 kinetics. The IEC33019 strain showed high resistance rates to β-lactams, ciprofloxacin and aminoglycosides, being susceptible only to polymyxins and susceptible, increased exposure to aztreonam. WGS analysis revealed a novel acquired MBL-encoding gene, blaBIM-1, found as a gene cassette inserted into a class 1 integron (In1326) that also carried qnrVC1 and aadA11e. In1326 was located in a complex transposon, Tn7122, carried by a 52.7 kb conjugative plasmid (pIEC33019) with a toxin/antitoxin system (vapB/vapC). BIM-1 belongs to the molecular subgroup B1 and shares 70.2% and 64.9% similarity with SIM-1 and IMP-1, respectively. Kinetics analysis of BIM-1 showed hydrolytic activity against all β-lactams tested. BIM-1 is a novel acquired MBL encoded by a gene carried by mobile genetic elements, which can be transferred to other Gram-negative bacilli (GNB). Because the IEC33019 strain was recovered from a river impacted by a populous metropolitan region with poor basic sanitation and served by limited potable freshwater, it would be important to establish the role of the BIM-1-producing GNB as nosocomial pathogens and/or as colonizers of the riverside population in this geographical region.
- 11 April 2023
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 78 (6) , 1359-1366
Open AccessGenetic and biochemical characterization of BIM-1, a novel acquired subgroup B1 MBL found in a Pseudomonas sp. strain from the Brazilian Amazon region
To characterize a novel acquired MBL, BIM-1, in a Pseudomonas #2 (subgroup P. guariconensis) strain isolated from the Aurá river located in the Brazilian Amazon hydrographic basin. WGS using an Illumina® MiSeq System was used to characterize the genome of Pseudomonas sp. IEC33019 strain. Southern blotting/hybridization assays were performed to confirm the location of the MBL-encoding gene, blaBIM-1 (Belém Imipenemase). Antimicrobial susceptibility testing, cloning, and biochemical and phenotypic characterization were performed to determine BIM-1 kinetics. The IEC33019 strain showed high resistance rates to β-lactams, ciprofloxacin and aminoglycosides, being susceptible only to polymyxins and susceptible, increased exposure to aztreonam. WGS analysis revealed a novel acquired MBL-encoding gene, blaBIM-1, found as a gene cassette inserted into a class 1 integron (In1326) that also carried qnrVC1 and aadA11e. In1326 was located in a complex transposon, Tn7122, carried by a 52.7 kb conjugative plasmid (pIEC33019) with a toxin/antitoxin system (vapB/vapC). BIM-1 belongs to the molecular subgroup B1 and shares 70.2% and 64.9% similarity with SIM-1 and IMP-1, respectively. Kinetics analysis of BIM-1 showed hydrolytic activity against all β-lactams tested. BIM-1 is a novel acquired MBL encoded by a gene carried by mobile genetic elements, which can be transferred to other Gram-negative bacilli (GNB). Because the IEC33019 strain was recovered from a river impacted by a populous metropolitan region with poor basic sanitation and served by limited potable freshwater, it would be important to establish the role of the BIM-1-producing GNB as nosocomial pathogens and/or as colonizers of the riverside population in this geographical region.
- 20 December 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (12) , e0083922
Characterization of a Carbapenem-Resistant BKC-1-Producing Clinical Isolate Belonging to the Pseudomonas putida Group from Brazil
Since its first report, the class A Brazilian Klebsiella carbapenemase (BKC) has been detected only among Enterobacterales isolates from Brazilian hospitals. In this study, we characterized a multidrug-resistant Pseudomonas juntendi clinical isolate and identified a 43.3-kb plasmid carrying bla BKC-1 and a class 1 integron (In 1996 ) containing the arr-2 , qnrVC1 , dfrA21 , and aac(6′)-Ib′ gene cassettes.
- 20 December 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (12) , e0083922
Characterization of a Carbapenem-Resistant BKC-1-Producing Clinical Isolate Belonging to the Pseudomonas putida Group from Brazil
Since its first report, the class A Brazilian Klebsiella carbapenemase (BKC) has been detected only among Enterobacterales isolates from Brazilian hospitals. In this study, we characterized a multidrug-resistant Pseudomonas juntendi clinical isolate and identified a 43.3-kb plasmid carrying bla BKC-1 and a class 1 integron (In 1996 ) containing the arr-2 , qnrVC1 , dfrA21 , and aac(6′)-Ib′ gene cassettes.
- Open Access
- 9 September 2022
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 26, 102397
DIVERSIDADE DE CARBAPENEMASES EM ESPÉCIES DE PSEUDOMONAS DO GRUPO PUTIDA
- 9 September 2022
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 26, 102397
Open AccessDIVERSIDADE DE CARBAPENEMASES EM ESPÉCIES DE PSEUDOMONAS DO GRUPO PUTIDA
- Open Access
- 9 September 2022
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 26, 102488
OCORRÊNCIA DE CASOS POSITIVOS DE SARS-COV-2 DURANTE A ONDA DE ÔMICRON EM UM HOSPITAL PÚBLICO DE SÃO PAULO
- 9 September 2022
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 26, 102488
Open AccessOCORRÊNCIA DE CASOS POSITIVOS DE SARS-COV-2 DURANTE A ONDA DE ÔMICRON EM UM HOSPITAL PÚBLICO DE SÃO PAULO